Hemex Is A Swiss Based Clinical Research Organizationcroand Investment Firm Established In 2011Focusing On The Life Sciences Sectorthe Company Supports Startups In Developing Innovative Drugsmedical Devicesand In Vitro Diagnostics By Providing A Platform To Connect Them With Potential Investorshemex Has Successfully Raised Significant Fundingincluding A Series C Financing Round Of 7 1 Million Swiss Francsaimed At Accelerating Global Expansion And Investing In Early Phase Startups The Company Offers A Wide Range Of Clinical Research Servicesincluding Clinical Study Start Upmanagementmonitoringregulatory Affairsquality Assurancedata Managementand Biostatisticshemex Conducts Clinical Trials Across Various Therapeutic Areas Such As Infectious Diseasescardiovascular Diseasesneurological Diseasesorthopedicsurologywomen S Healthand Oncologyadditionallyhemex Invests In Early Phase Startupsproviding Capital To Support The Development Of Innovative Healthcare Solutions
